Startups

Theolytics

Develops oncolytic virus therapies for cancer, using phenotypic screening to select viruses that kill cancer cells and stimulate antitumor immune responses.

Team

David ApelianCEO and CMO

Luke HarrisHead of Finance

Margaret DuffyCSO and Co-Founder

Investments

$—Unknown date

Epidarex Capital